How Gut Hormones Explain Why Bariatric Surgery Causes Weight Loss
Bariatric surgery produces weight loss partly by increasing appetite-suppressing gut hormones like GLP-1, PYY, and oxyntomodulin while decreasing the hunger hormone ghrelin.
Quick Facts
What This Study Found
Appetite is regulated by two sets of neurons in the hypothalamus. POMC neurons (activated by satiety hormones) suppress appetite. NPY/AgRP neurons (activated by hunger signals) promote eating. Gut hormones modulate this balance.
After bariatric surgery, the key changes include: increased GLP-1 (which suppresses appetite and improves blood sugar), increased PYY (peptide YY, which signals fullness), increased oxyntomodulin (which reduces food intake), and decreased ghrelin (the hunger hormone).
The review highlights that GLP-1 receptor agonists pharmacologically replicate part of this post-surgical response. This explains their effectiveness for weight loss even without surgery. The review also notes that genetic testing can now identify monogenic and polygenic obesity, potentially guiding individualized treatment.
Key Numbers
- GLP-1, PYY, oxyntomodulin, CCK: increased after bariatric surgery
- Ghrelin: decreased after bariatric surgery
- POMC neurons: activated by anorexigenic hormones
- NPY/AgRP neurons: activated by orexigenic signals
- Obesity has both monogenic and polygenic genetic components
How They Did This
Narrative review of the physiology of appetite control, including the hypothalamic arcuate nucleus signaling, gut-brain hormone communication, bariatric surgery outcomes, and obesity genetics. Covers both basic science and clinical evidence.
Why This Research Matters
Understanding why bariatric surgery works at the hormonal level has directly led to the development of GLP-1 drugs for weight loss. This review connects the dots between surgical outcomes, gut hormone physiology, and drug development. It also introduces the concept of personalized obesity treatment based on genetic profiles.
The Bigger Picture
Understanding why bariatric surgery works at the hormonal level directly led to GLP-1 weight loss drugs. This review connects surgical outcomes to pharmaceutical development.
What This Study Doesn't Tell Us
This is a narrative review without systematic methodology or pooled analysis. It covers a broad scope (physiology, surgery, genetics, pharmacology) at a high level without deep analysis of any single topic. The genetic section is brief and does not detail specific gene-treatment matching. The review does not address long-term safety of GLP-1 drugs or compare them quantitatively to surgery.
Questions This Raises
- ?Could a multi-hormone drug cocktail replicate the full effect of bariatric surgery?
- ?Does ghrelin suppression contribute more to weight loss than GLP-1 elevation?
Trust & Context
- Key Stat:
- Multiple hormones change Bariatric surgery simultaneously increases at least four satiety hormones and decreases the hunger hormone ghrelin
- Evidence Grade:
- Rated strong: comprehensive review synthesizing well-established physiological mechanisms with extensive supporting evidence from surgery and pharmacology research.
- Study Age:
- Published in 2024. Integrates decades of gut hormone research with current understanding of obesity pharmacotherapy.
- Original Title:
- Physiological Appetite Regulation and Bariatric Surgery.
- Published In:
- Journal of clinical medicine, 13(5) (2024)
- Authors:
- Ramasamy, Indra
- Database ID:
- RPEP-09115
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Why does bariatric surgery cause weight loss?
Beyond stomach size reduction, surgery changes gut hormones: appetite-suppressing hormones increase while the hunger hormone ghrelin decreases.
How did bariatric surgery lead to GLP-1 drugs?
Researchers noticed that GLP-1 levels rose dramatically after surgery and contributed to weight loss. This insight led to developing synthetic GLP-1 drugs.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09115APA
Ramasamy, Indra. (2024). Physiological Appetite Regulation and Bariatric Surgery.. Journal of clinical medicine, 13(5). https://doi.org/10.3390/jcm13051347
MLA
Ramasamy, Indra. "Physiological Appetite Regulation and Bariatric Surgery.." Journal of clinical medicine, 2024. https://doi.org/10.3390/jcm13051347
RethinkPeptides
RethinkPeptides Research Database. "Physiological Appetite Regulation and Bariatric Surgery." RPEP-09115. Retrieved from https://rethinkpeptides.com/research/ramasamy-2024-physiological-appetite-regulation-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.